BET inhibitor apabetalone (RVX-208) downregulates the complement cascade in primary human hepatocytes, in mice and in cardiovascular disease human patients. (September 2017) - Wasiak, Sylwia; Gilham, Dean; Tsujikawa, Laura M.; Halliday, Christopher; Calosing, Cyrus; Jahagirdar, Ravi; Johansson, Jan; Sweeney, Michael; Wong, Norman C.; Kulikowski, Ewelina